Raiders of the lost mark – endothelial cells and their role in transplantation for hematologic malignancies

References

• Ferrara F, Schiffer CA. Acute myeloid leukaemia in adults. Lancet. 2013;381:484–495.
   PubMed Web of Science ®Google Scholar
• Bassan R, Hoelzer D. Modern therapy of acute lymphoblastic leukemia. J Clin Oncol. 2011;29:532–543.
   PubMed Web of Science ®Google Scholar
• Klyuchnikov E, Bacher U, Kroll T, et al. Allogeneic hematopoietic cell transplantation for diffuse large B cell lymphoma: who, when and how[quest]. Bone Marrow Transplant. 2014;49:1–7.
   PubMed Web of Science ®Google Scholar
• Casulo C, Burack WR, Friedberg JW. Transformed follicular non-Hodgkin lymphoma. Blood 2015;125:40–47.
   PubMed Web of Science ®Google Scholar
• Schmitz N, Pfistner B, Sextro M, et al. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin’s disease: a randomised trial. Lancet. 2002;359:2065–2071.
   PubMed Web of Science ®Google Scholar
• Child JA, Morgan GJ, Davies FE, et al. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med. 2003;348:1875–1883.
   PubMed Web of Science ®Google Scholar
• Lapidot T, Dar A, Kollet O. How do stem cells find their way home? Blood. 2005;106:1901–1910.
   PubMed Web of Science ®Google Scholar
• Rafii S, Lyden D, Benezra R, et al. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? Nat Rev Cancer. 2002;2:826–835.
   PubMed Web of Science ®Google Scholar
• Cao Z, Ding BS, Guo P, et al. Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance. Cancer Cell. 2014;25:350–365.
   PubMed Web of Science ®Google Scholar
• Hooper AT, Butler JM, Nolan DJ, et al. Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells. Cell Stem Cell. 2009;4:263–274.
   PubMed Web of Science ®Google Scholar
• Butler JM, Nolan DJ, Vertes EL, et al. Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells. Cell Stem Cell. 2010;6:251–264.
   PubMed Web of Science ®Google Scholar
• Morrison SJ, Scadden DT. The bone marrow niche for haematopoietic stem cells. Nature. 2014;505:327–334.
   PubMed Web of Science ®Google Scholar
• Sandler VM, Lis R, Liu Y, et al. Reprogramming human endothelial cells to haematopoietic cells requires vascular induction. Nature. 2014;511:312–318.
   PubMed Web of Science ®Google Scholar
• Tamplin OJ, Durand EM, Carr LA, et al. Hematopoietic stem cell arrival triggers dynamic remodeling of the perivascular niche. Cell. 2015;160:241–252.
   PubMed Web of Science ®Google Scholar
• Zöller M. CD44, hyaluronan, the hematopoietic stem cell and leukemia-initiating cells. Front Immunol. 2015;6:235. doi:10.3389/fimmu.2015.00235.
   PubMed Web of Science ®Google Scholar
• Krause DS, Lazarides K, Lewis JB, et al. Selectins and their ligands are required for homing and engraftment of BCR-ABL1+ leukemic stem cells in the bone marrow niche. Blood. 2014;123:1361–1371.
   PubMed Web of Science ®Google Scholar
• Almici C, Skert C, Verardi R, et al. Changes in circulating endothelial cells count could become a valuable tool in the diagnostic definition of acute graft-versus-host disease. Transplantation. 2014;98:706–712.
   PubMed Web of Science ®Google Scholar
• Carreras E, Diaz-Ricart M. The role of the endothelium in the short-term complications of hematopoietic SCT. Bone Marrow Transplant. 2011;46:1495–1502.
   PubMed Web of Science ®Google Scholar
• DeLeve LD, Ito Y, Bethea NW, et al. Embolization by sinusoidal lining cells obstructs the microcirculation in rat sinusoidal obstruction syndrome. Am J Physiol Gastrointest Liver Physiol. 2003;284:G1045–G1052.
   PubMed Web of Science ®Google Scholar
• Pigott R, Dillon LP, Hemingway IH, et al. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun. 1992;187:584–589.
   PubMed Web of Science ®Google Scholar
• Elangbam CS, Qualls CW, Dahlgren RR . Cell Adhesion molecules-update. Vet Pathol. 1997;34:61–73. Online
   PubMed Web of Science ®Google Scholar
• Swiatkowska M, Szemraj J, Cierniewski CS . Induction of PAI-1 expression by tumor necrosis factor alpha in endothelial cells is mediated by its responsive element located in the 4G/5G site. FEBS J. 2005;272:5821–5831.
   PubMed Web of Science ®Google Scholar
• Blann A, Seigneur M. Soluble markers of endothelial cell function. Clin Hemorheol Microcirc. 1997;17:3–11.
   PubMed Web of Science ®Google Scholar
• PEARSON JD. Markers of endothelial perturbation and damage. Br J Rheumatol. 1993;32:651–652.
   PubMedGoogle Scholar
• Takahashi H, Ito S, Hanano M, et al. Circulating thrombomodulin as a novel endothelial cell marker: comparison of its behavior with von Willebrand factor and tissue-type plasminogen activator. Am J Hematol. 1992;41:32–39.
   PubMed Web of Science ®Google Scholar
• Sarrazin S, Adam E, Lyon M, et al. Endocan or endothelial cell specific molecule-1 (ESM-1): A potential novel endothelial cell marker and a new target for cancer therapy. Biochim Biophys Acta. 2006;1765:25–37.
   PubMed Web of Science ®Google Scholar
• Ryningen A, Stapnes C, Paulsen K, et al. In vivo biological effects of ATRA in the treatment of AML. Expert Opin Investig Drugs. 2008;17:1623–1633.
   PubMed Web of Science ®Google Scholar
• Kwak HJ, Lee SJ, Lee Y-H, et al. Angiopoietin-1 inhibits irradiation- and mannitol-induced apoptosis in endothelial cells. Circulation. 2000;101:2317–2324.
   PubMed Web of Science ®Google Scholar
• Maisonpierre PC, Suri C, Jones PF, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science. 1997;277:55–60.
   PubMed Web of Science ®Google Scholar
• Vajkoczy P, Farhadi M, Gaumann A, et al. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2. J Clin Invest. 2002;109:777–785.
   PubMed Web of Science ®Google Scholar
• Eissner G, Multhoff G, Gerbitz A, et al. Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide. Blood. 2002;100:334–340.
   PubMed Web of Science ®Google Scholar
• Ohtani T, Nakamura T, Toda K-i, et al . Cyclophosphamide enhances TNF-alpha-induced apoptotic cell death in murine vascular endothelial cell. FEBS Lett. 2006;580:1597–1600.
   PubMed Web of Science ®Google Scholar
• Haimovitz-Friedman A, Vlodavsky I, Chaudhuri A, et al. Autocrine effects of fibroblast growth factor in repair of radiation damage in endothelial cells. Cancer Res. 1991;51:2552–2558.
   PubMed Web of Science ®Google Scholar
• Eissner G, Kohlhuber F, Grell M, et al. Critical involvement of transmembrane tumor necrosis factor-alpha in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxin. Blood. 1995;86:4184–4193.
   PubMed Web of Science ®Google Scholar
• Mercanoglu F, Turkmen A, Kocaman O, et al. Endothelial dysfunction in renal transplant patients is closely related to serum cyclosporine levels. Transplant Proc. 2004;36:1357–1360.
   PubMed Web of Science ®Google Scholar
• Woywodt A, Schroeder M, Gwinner W, et al. Elevated numbers of circulating endothelial cells in renal transplant recipients. Transplantation. 2003;76:1–4.
   PubMed Web of Science ®Google Scholar
• Fuste B, Mazzara R, Escolar G, et al. Granulocyte colony-stimulating factor increases expression of adhesion receptors on endothelial cells through activation of p38 MAPK. Haematologica. 2004;89:578–585.
   PubMed Web of Science ®Google Scholar
• Ganster A, Brucker I, Holler E, et al. In vitro monitoring of endothelial complications following hematopoietic allogeneic stem cell transplantation. Bone Marrow Transplant. 2003;33:355–357.
   Web of Science ®Google Scholar
• Eissner G, Multhoff G, Holler E. Influence of bacterial endotoxin on the allogenicity of human endothelial cells. Bone Marrow Transplant. 1998;21:1286–1288.
   PubMed Web of Science ®Google Scholar
• Biedermann BC, Sahner S, Gregor M, et al. Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease. Lancet. 2002;359:2078–2083.
   PubMed Web of Science ®Google Scholar
• Cohen H, Bull HA, Seddon A, et al. Vascular endothelial cell function and ultrastructure in thrombotic microangiopathy following allogeneic bone marrow transplantation. Eur J Haematol. 1989;43:207–214.
   PubMed Web of Science ®Google Scholar
• Richard S, Seigneur M, Blann A, et al. Vascular endothelial lesion in patients undergoing bone marrow transplantation. Bone Marrow Transplant. 1996;18:955–959.
   PubMed Web of Science ®Google Scholar
• Matsuda Y, Hara J, Osugi Y, et al. Serum levels of soluble adhesion molecules in stem cell transplantation-related complications. Bone Marrow Transplant. 2001;27:977–982.
   PubMed Web of Science ®Google Scholar
• Palomo M, Diaz-Ricart M, Carbo C, et al. Endothelial dysfunction after hematopoietic stem cell transplantation: role of the conditioning regimen and the type of transplantation. Biol Blood Marrow Transplant. 2010;16:985–993.
   PubMed Web of Science ®Google Scholar
• Lindas R, Tvedt TH, Hatfield KJ, et al. Preconditioning serum levels of endothelial cell-derived molecules and the risk of posttransplant complications in patients treated with allogeneic stem cell transplantation. J Transplant. 2014;2014:404096
   PubMedGoogle Scholar
• Palomo M, Diaz-Ricart M, Rovira M, et al. Defibrotide prevents the activation of macrovascular and microvascular endothelia caused by soluble factors released to blood by autologous hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2011;17:497–506.
   PubMed Web of Science ®Google Scholar
• Mohty M, Malard F, Abecassis M, et al. Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives[mdash]a position statement from the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 2015;50:781–789.
   PubMed Web of Science ®Google Scholar
• Corbacioglu S, Cesaro S, Faraci M, et al. Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial. Lancet. 2012;379:1301–1309.
   PubMed Web of Science ®Google Scholar
• Catani L, Gugliotta L, Vianelli N, et al. Endothelium and bone marrow transplantation. Bone Marrow Transplant. 1996;17:277–280.
   PubMed Web of Science ®Google Scholar
• Testa S, Manna A, Porcellini A, et al. Increased plasma level of vascular endothelial glycoprotein thrombomodulin as an early indicator of endothelial damage in bone marrow transplantation. Bone Marrow Transplant. 1996;18:383–388.
   PubMed Web of Science ®Google Scholar
• Zeigler ZR, Rosenfeld CS, Andrews DF, et al. Plasma von Willebrand factor antigen (vWF:AG) and thrombomodulin (TM) levels in adult thrombotic thrombocytopenic purpura/hemolytic uremic syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM). Am J Hematol. 1996;53:213–220.
   PubMed Web of Science ®Google Scholar
• Salat C, Holler E, Kolb HJ, et al. Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versus-host disease. Bone Marrow Transplant. 1997;19:909–914.
   PubMed Web of Science ®Google Scholar
• Nurnberger W, Michelmann I, Burdach S, et al. Endothelial dysfunction after bone marrow transplantation: increase of soluble thrombomodulin and PAI-1 in patients with multiple transplant-related complications. Ann Hematol. 1998;76:61–65.
   PubMed Web of Science ®Google Scholar
• Dietrich S, Falk CS, Benner A, et al. Endothelial vulnerability and endothelial damage are associated with risk of graft-versus-host disease and response to steroid treatment. Biol Blood Marrow Transplant. 2013;19:22–27.
   PubMed Web of Science ®Google Scholar
• Luzzatto G, Cella G, Messina C, et al. Markers of endothelial function in pediatric stem cell transplantation for acute leukemia. Med Pediatr Oncol. 2003;40:9–12.
   PubMedGoogle Scholar
• Woywodt A, Scheer J, Hambach L, et al. Circulating endothelial cells as a marker of endothelial damage in allogeneic hematopoietic stem cell transplantation. Blood. 2004;103:3603–3605.
   PubMed Web of Science ®Google Scholar
• Kideryova L, Pytlik R, Benesova K, et al. Endothelial cells (EC) and endothelial precursor cells (EPC) kinetics in hematological patients undergoing chemotherapy or autologous stem cell transplantation (ASCT). Hematol Oncol. 2010;28:192–201.
   PubMed Web of Science ®Google Scholar
• Szmigielska-Kaplon A, Krawczynska A, Czemerska M, et al. The kinetics and apoptotic profile of circulating endothelial cells in autologous hematopoietic stem cell transplantation in patients with lymphoproliferative disorders. Ann Hematol. 2013;92:1255–1262.
   PubMed Web of Science ®Google Scholar
• Shimura K, Ashihara E, Shimazaki C, et al. Circulating endothelial progenitor cells decreased in patients with sclerodermatous chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2008;14:426–437.
   PubMed Web of Science ®Google Scholar
• Rio B, Petropoulou AD, Mirshahi P, et al. Endothelial cell markers’ kinetics following umbilical cord blood transplantation. Leuk Lymphoma. 2008;49:2209–2212.
   PubMed Web of Science ®Google Scholar
• Beije N, Versluis J, Kraan J, et al. Circulating endothelial cell enumeration demonstrates prolonged endothelial damage in recipients of myeloablative allogeneic stem cell transplantation. Haematologica. 2015;100:e246–e249.
   PubMed Web of Science ®Google Scholar
• Zeng L, Yan Z, Wang L, et al. Irradiation is an early determinant of endothelial injury during hematopoietic stem cell transplantation. Transplant Proc. 2008;40:2661–2664.
   PubMed Web of Science ®Google Scholar
• Armenian SH, Sun C-L, Vase T, et al. Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease. Blood. 2012;120:4505–4512.
   PubMed Web of Science ®Google Scholar
• Yan Z, Zeng L, Jia L, et al. Increased numbers of circulating ECs are associated with systemic GVHD. Int J Lab Hematol. 2011;33:507–515.
   PubMed Web of Science ®Google Scholar
• Woywodt A, Haubitz M, Buchholz S, et al. Counting the cost: markers of endothelial damage in hematopoietic stem cell transplantation. Bone Marrow Transplant. 2004;34:1015–1023.
   PubMed Web of Science ®Google Scholar
• Vacca A, Ribatti D, Roncali L, et al. Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol. 1994;87:503–508.
   PubMed Web of Science ®Google Scholar
• Rajkumar SV, Fonseca R, Witzig TE, et al. Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma. Leukemia. 1999;13:469–472.
   PubMed Web of Science ®Google Scholar
• Munshi NC, Wilson C. Increased bone marrow microvessel density in newly diagnosed multiple myeloma carries a poor prognosis. Semin Oncol. 2001;28:565–569.
   PubMed Web of Science ®Google Scholar
• Kumar S, Gertz MA, Dispenzieri A, et al. Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy. Bone Marrow Transplant. 2004;34:235–239.
   PubMed Web of Science ®Google Scholar
• Oh HS, Choi JH, Park CK, et al. Comparison of microvessel density before and after peripheral blood stem cell transplantation in multiple myeloma patients and its clinical implications: multicenter trial. Int J Hematol. 2002;76:465–470.
   PubMed Web of Science ®Google Scholar
• Perez-Atayde AR, Sallan SE, Tedrow U, et al. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol. 1997;150:815–821.
   PubMed Web of Science ®Google Scholar
• Hussong JW, Rodgers GM, Shami PJ. Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood. 2000;95:309–313.
   PubMed Web of Science ®Google Scholar
• Padró T, Ruiz S, Bieker R, et al. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood. 2000;95:2637–2644.
   PubMed Web of Science ®Google Scholar
• Medinger M, Tichelli A, Bucher C, et al. GVHD after allogeneic haematopoietic SCT for AML: angiogenesis, vascular endothelial growth factor and VEGF receptor expression in the BM. Bone Marrow Transplant. 2013;48:715–721.
   PubMed Web of Science ®Google Scholar
• Keith T, Araki Y, Ohyagi M, et al. Regulation of angiogenesis in the bone marrow of myelodysplastic syndromes transforming to overt leukaemia. Br J Haematol. 2007;137:206–215.
   PubMed Web of Science ®Google Scholar
• Kini AR, Kay NE, Peterson LC. Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia. Leukemia. 2000;14:1414–1418.
   PubMed Web of Science ®Google Scholar
• Cardesa-Salzmann TM, Colomo L, Gutierrez G, et al. High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy. Haematologica. 2011;96:996–1001.
   PubMed Web of Science ®Google Scholar
• Jorgensen JM, Sorensen FB, Bendix K, et al. Angiogenesis in non-Hodgkin’s lymphoma: clinico-pathological correlations and prognostic significance in specific subtypes. Leuk Lymphoma. 2007;48:584–595.
   PubMed Web of Science ®Google Scholar
• Kawano M, Hirano T, Matsuda T, et al. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature. 1988;332:83–85.
   PubMed Web of Science ®Google Scholar
• Dankbar B, Padró T, Leo R, et al. Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma. Blood. 2000;95:2630–2636.
   PubMed Web of Science ®Google Scholar
• Hintsala E, Bono P, Andersson S, et al. Quantification of plasma and bone marrow VEGF and angiopoietin-2 levels in pediatric malignancies. J Pediatr Hematol Oncol. 2012;34:503–510.
   PubMed Web of Science ®Google Scholar
• Stachel D, Albert M, Meilbeck R, et al. Expression of angiogenic factors in childhood B-cell precursor acute lymphoblastic leukemia. Oncol Rep. 2007;17:147–152.
   PubMed Web of Science ®Google Scholar
• Faderl S, Do K-A, Johnson MM, et al. Angiogenic factors may have a different prognostic role in adult acute lymphoblastic leukemia. Blood. 2005;106:4303–4307.
   PubMed Web of Science ®Google Scholar
• Moiseev IS, Lapin SV, Surkova EA, et al. Level of vascular endothelial growth factor predicts both relapse and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2013;19:1677–1682.
   PubMed Web of Science ®Google Scholar
• Sucak GT, Aki SZ, Yuzbasioglu B, et al. Prognostic value of bone marrow microvessel density and angiogenic cytokines in patients with multiple myeloma undergoing autologous stem cell transplant. Leuk Lymphoma. 2011;52:1281–1289.
   PubMed Web of Science ®Google Scholar
• Thompson MA, Witzig TE, Kumar S, et al. Plasma levels of tumour necrosis factor alpha and interleukin-6 predict progression-free survival following thalidomide therapy in patients with previously untreated multiple myeloma. Br J Haematol. 2003;123:305–308.
   PubMed Web of Science ®Google Scholar
• Andersen NF, Standal T, Nielsen JL, et al. Syndecan-1 and angiogenic cytokines in multiple myeloma: correlation with bone marrow angiogenesis and survival. Br J Haematol. 2005;128:210–217.
   PubMed Web of Science ®Google Scholar
• Cortelezzi A, Fracchiolla NS, Mazzeo LM, et al. Endothelial precursors and mature endothelial cells are increased in the peripheral blood of myelodysplastic syndromes. Leuk Lymphoma. 2005;46:1345–1351.
   PubMed Web of Science ®Google Scholar
• Della Porta MG, Malcovati L, Rigolin GM, et al. Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromes. Leukemia. 2007;22:530–537.
   PubMed Web of Science ®Google Scholar
• Wierzbowska A, Robak T, Krawczyńska A, et al. Circulating endothelial cells in patients with acute myeloid leukemia. Eur J Haematol. 2005;75:492–497.
   PubMed Web of Science ®Google Scholar
• Wierzbowska A, Robak T, Krawczyńska A, et al. Kinetics and apoptotic profile of circulating endothelial cells as prognostic factors for induction treatment failure in newly diagnosed acute myeloid leukemia patients. Ann Hematol. 2008;87:97–106.
   PubMed Web of Science ®Google Scholar
• Rigolin GM, Maffei R, Rizzotto L, et al . Circulating endothelial cells in patients with chronic lymphocytic leukemia: clinical-prognostic and biologic significance. Cancer. 2010;116:1926–1937.
   PubMed Web of Science ®Google Scholar
• Zhang H, Vakil V, Braunstein M, et al. Circulating endothelial progenitor cells in multiple myeloma: implications and significance. Blood. 2005;105:3286–3294.
   PubMed Web of Science ®Google Scholar
• Bhaskar A, Gupta R, Kumar L, et al. Circulating endothelial progenitor cells as potential prognostic biomarker in multiple myeloma. Leuk Lymphoma. 2012;53:635–640.
   PubMed Web of Science ®Google Scholar
• Blix ES, Kildal AB, Bertelsen E, et al. Content of endothelial progenitor cells in autologous stem cell grafts predict survival after transplantation for multiple myeloma. Biol Blood Marrow Transplant. 2015;21:840–847.
   PubMed Web of Science ®Google Scholar
• Udi J, Wider D, Kleber M, et al. Early and mature endothelial progenitors and VEGFR2+-cells in multiple myeloma: association with disease characteristics and variation in different cell compartments. Leuk Res. 2011;35:1265–1268.
   PubMed Web of Science ®Google Scholar
• Igreja C, Courinha M, Cachaço AS, et al. Characterization and clinical relevance of circulating and biopsy-derived endothelial progenitor cells in lymphoma patients. Haematologica. 2007;92:469–477.
   PubMed Web of Science ®Google Scholar
• Bertolini F, Shaked Y, Mancuso P, et al. The multifaceted circulating endothelial cell in cancer: towards marker and target identification. Nat Rev Cancer. 2006;6:835–845.
   PubMed Web of Science ®Google Scholar
• Kerbel RS. Tumor Angiogenesis. N Engl J Med. 2008;358:2039–2049.
   PubMed Web of Science ®Google Scholar
• Gao D, Nolan DJ, Mellick AS, et al. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science. 2008;319:195–198.
   PubMed Web of Science ®Google Scholar
• Purhonen S, Palm J, Rossi D, et al. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc Natl Acad Sci. 2008;105:6620–6625.
   PubMed Web of Science ®Google Scholar
• Kerbel RS, Benezra R, Lyden DC, et al. Endothelial progenitor cells are cellular hubs essential for neoangiogenesis of certain aggressive adenocarcinomas and metastatic transition but not adenomas. Proc Natl Acad Sci. 2008;105:E54.
   PubMedGoogle Scholar
• Piaggio G, Rosti V, Corselli M, et al. Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker. Blood. 2009;114:3127–3130.
   PubMed Web of Science ®Google Scholar
• Case J, Mead LE, Bessler WK, et al. Human CD34 + AC133 + VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol. 2007;35:1109–1118.
   PubMed Web of Science ®Google Scholar
• Basile DP, Yoder MC. Circulating and tissue resident endothelial progenitor cells. J Cell Physiol. 2014;229:10–16.
   PubMed Web of Science ®Google Scholar
• Fadini GP, Losordo D, Dimmeler S. Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ Res. 2012;110:624–637.
   PubMed Web of Science ®Google Scholar
• Kumpers P, Koenecke C, Hecker H, et al. Angiopoietin-2 predicts disease-free survival after allogeneic stem cell transplantation in patients with high-risk myeloid malignancies. Blood. 2008;112:2139–2148.
   PubMed Web of Science ®Google Scholar
• Lee CY, Tien HF, Hu CY, et al. Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia. Br J Cancer. 2007;97:877–882.
   PubMed Web of Science ®Google Scholar
• Schliemann C, Bieker R, Thoennissen N, et al. Circulating angiopoietin-2 is a strong prognostic factor in acute myeloid leukemia. Leukemia. 2007;21:1901–1906.
   PubMed Web of Science ®Google Scholar
• Koenecke C, Kumpers P, Lukasz A, et al. Shedding of the endothelial receptor tyrosine kinase Tie2 correlates with leukemic blast burden and outcome after allogeneic hematopoietic stem cell transplantation for AML. Ann Hematol. 2010;89:459–467.
   PubMed Web of Science ®Google Scholar
• Reikvam H, Hatfield KJ, Lassalle P, et al. Targeting the angiopoietin (Ang)/Tie-2 pathway in the crosstalk between acute myeloid leukaemia and endothelial cells: studies of Tie-2 blocking antibodies, exogenous Ang-2 and inhibition of constitutive agonistic Ang-1 release. Exp Opin Invest Drugs. 2010;19:169–183.
   PubMed Web of Science ®Google Scholar
• Cogle CR, Goldman DC, Madlambayan GJ, et al. Functional integration of acute myeloid leukemia into the vascular niche. Leukemia. 2014;28:1978–1987.
   PubMed Web of Science ®Google Scholar
• Rigolin GM, Fraulini C, Ciccone M, et al. Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion. Blood. 2006;107:2531–2535.
   PubMed Web of Science ®Google Scholar
• Rigolin GM, Mauro E, Ciccone M, et al. Neoplastic circulating endothelial-like cells in patients with acute myeloid leukaemia. Eur J Haematol. 2007;78:365–373.
   PubMed Web of Science ®Google Scholar
• Gunsilius E, Duba H-C, Petzer AL, et al. Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet. 2000;355:1688–1691.
   PubMed Web of Science ®Google Scholar
• Oppliger Leibundgut E, Horn M, Brunold C, et al. Hematopoietic and endothelial progenitor cell trafficking in patients with myeloproliferative diseases. Haematologica. 2006;91:1465–1472.
   PubMed Web of Science ®Google Scholar
• Streubel B, Chott A, Huber D, et al. Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-Cell lymphomas. N Engl J Med. 2004;351:250–259.
   PubMed Web of Science ®Google Scholar
• Peters BA, Diaz LA, Polyak K, et al. Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat Med. 2005;11:261–262.
   PubMed Web of Science ®Google Scholar
• Ramos TL, Sánchez-Abarca LI, López-Ruano G, et al. Do endothelial cells belong to the primitive stem leukemic clone in CML? Role of extracellular vesicles. Leuk Res. 2015;39:921–924.
   PubMed Web of Science ®Google Scholar